CompletedNot Applicable

Breathing Parameter Measurements for Lung Deposition Simulation

Hungary163 participantsStarted 2022-09-01

Plain-language summary

This study aims to simulate the deposition of aerosol drugs within the airways of asthma and COPD patients based on realistic breathing patterns measured at different pulmonology centers. Further goal of the study is to find correlations between the amount of drug depositing in the lungs and the measured breathing parameters, as well as disease status and demographic data. The results of the study will be part of a major objective targeting the optimization and personalization of aerosol drug therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed obstructive lung disease (asthma or COPD) * proper usage of inhalation tool after being educated * availability of whole body plethysmography measurement data from the last 6 months or the possibility to perform them before the start of the study * subject under outpatient/inpatient therapy * capable of acting and cooperating Exclusion Criteria: * the patient doesn't align with any of the criteria mentioned above * the patient is incapable of filling out the questionnaire/questionnaires' parts that are accorded to him/her * the patient doesn't agree to have data collected of him/her * diagnosed heavy, not treated chronic illness * not properly carried out /not evaluable lung function (spirometry) examination

What they're measuring

Lung deposition fraction

Timeframe: July 1, 2023 - June 30, 2025

Trial details

NCT IDNCT05445349

SponsorMedisol Development Kft.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Asthma trials